Why Mothers Kiss Their Babies? — Does Immune System Play as a Protective Receptor of Chemical Determinants Involved in Mother-Infant Bonding? |
Author : ST Hossain, S Barik |
Abstract | Full Text |
Abstract :Mother-child bonding is not confined to human beings, rather all living animals show baby love. It is quite interesting to
intervene in the mechanisms or causative factors of this affection and its consequences. In this article, we attempt to
delineate that the chemical factors could be responsible for the affection or aggressiveness which ultimately leads to
induce passive immunity in newborn against external harmful pathogens among mammals. |
|
The COVID-19 Pandemic |
Author : Jadab Chandra Chattopadhyay |
Abstract | Full Text |
Abstract :Recent COVID-19 pandemic has caused the greatest crisis in human civilisation worldwide. Initially started in Wuhan,
China it has gradually spread all over the world due to the time taken by the people to understand the seriousness of
the disease. Initial symptoms are unremarkable and typical of upper respiratory tract viral infection, followed by dry
unproductive coughing, low grade fever and ultimately full blown feature of pneumonia requiring hospitalisation and
respiratory assistance including ICU and ventilation. Older adults, immunocompromised patients and those with several co-morbidities fall in higher risk categories irrespective of age. In this paper the origin, spread of infection and
virulence, preventive steps, diagnosis and recent trends in clinical management is discussed in detail. Future implications on socio-economic point of view is mentioned in global as well as in national perspective. |
|
Structural Bioinformatics Predicts Large Intrinsically Disordered Regions of Erythrocyte Binding-Like Proteins of Plasmodium sp.: Functional Implications |
Author : Arita Acharjee |
Abstract | Full Text |
Abstract :The Erythrocyte Binding Ligand (EBL) is an important protein of Plasmodium sp. required by the parasite for
successful invasion into the red blood cells causing malaria. EBL is a potential anti-malarial drug target. Despite its
importance only a portion of its structure i.e., Duffy Binding Domain (DBD), is solved. Thus, the remaining regions
necessitate attention and probing. In this study, it is reported that EBL protein consists of massive unstructured
regions in between two compact structured portions, viz., the DBD and a C-terminus trans-membrane domain as
predicted from our bioinformatics studies on Plasmodium vivax. Our study reveals that its major parts of the
unstructured portions consist of Intrinsically Disordered Regions (IDR). Since IDRs have high rates of plasticity, the
hypothesis is that it allows large molecular movements between the two structured portions of EBL helping the DBD
to find its target receptor. Here, a schematic of the overall structural organization of EBL and its functional model is
proposed. Thus, our study signifies possible importance of hitherto unexplored ‘disordered’-ness in EBLs in
mediating pathogenesis in Plasmodium sp. |
|
Resolution Revolutions on the Cryo-EM Structures of Ribosome- A Study: 1981-2018 |
Author : A Acharjee, A Chatterjee |
Abstract | Full Text |
Abstract :Ribosomes are large ribonucleoprotein complexes that have been proved to be ideal biological sample for the
development of the cryo-Electron Microscopy (cryo-EM) field. On the other hand, advancement in cryo-EM
technologies have helped in elucidating detailed structure-function aspects of various kinds of ribosomes, belonging
to prokaryotic, organellar, and complex eukaryotic systems. In a relatively short duration of time, through rapid
technological advances, cryo-EM has generated number of ribosome structures from sub atomic to atomic resolutions
with the capability of visualizing the side chain interactions of protein structures. This has given us the scope to
visualize various drugs and their binding sites on the ribosomes, wherefrom there are greater chances to improve
further and modify the drugs and verify their efficacy. This review provides an account of the improvement of the
cryo-EM in the light of performing research on ribosomes and understanding some of the ribosome’s structurefunction aspects in further details.
|
|
Combination Approach of Hyperthermia and Poly (ADPribose) Polymerase (PARP) Inhibitors in Cancer Treatment- A Brief Review |
Author : Sayantani Karmakar and Siddikuzzaman |
Abstract | Full Text |
Abstract :Cancer is among the leading causes of death worldwide. The key therapeutic modalities to treat cancer include chemotherapy, hormonal therapy, targeted therapy, immuno-therapy and combination therapy. A number of chemical agents
target DNA; they cause breaks, intercalation and cross-links to damage DNA thereby inhibiting cell proliferation. Cisplatin
and taxol based chemotherapies are still the most used chemotherapeutic agents which is commonly used for treating
many different tumor types, including head and neck, lung, testis, ovarian, cervix and breast. In spite of being in the primary line of treatment modality, resistance to cisplatin is one the major limitation in cancer treatment. This is why the
concept of combination therapies came into scene. Degradation of BRCA2 by hyperthermia causes abnormal localization
of RAD51 which, in turn, attenuates the process of DNA repair via HR. Hyperthermia, in combination with PARP inhibitors
is now a day is one of the best choices that is describes by several authors. This is an alternative combination to kill cancer
cells causing minimum damage to normal cells.
This review explores why hyperthermia should be chosen as a better modality of treatment to treat cancer in
combination with PARP inhibitors. |
|
The Current Therapeutic and Vaccine Pipeline of COVID-19 |
Author : Asama Mukherjee |
Abstract | Full Text |
Abstract :The COVID-19 pandemic has posed a menace to human life worldwide. This has triggered the thrust for the development of effective therapeutics and vaccines based on varied strategies. The trend for the repurposing of approved
molecules or those already in the clinical stage of development for other indications has been currently explored to
facilitate speedy identification of safe and effective drugs. Passive immunization through use of monoclonal antibodies and convalescent plasma therapy has been an investigational treatment from our previous knowledge of SARS
and MERS. The landscape for vaccine development represents several novel agents based on diverse technologies
that have already entered into fast track clinical trials. A new paradigm for identifying safe and immunogenic vaccines may be achieved through adaptive development and innovative regulatory process to address the unmet need
in a short span compared to the conventional timeframe. This article aims to consolidate the status of the therapeutics and vaccines in the developmental pipeline for COVID-19.
|
|